Trulieve Cannabis TRLV
NYSE TRLV
$9.65 +0.18 (+1.90%)
At close: Aug 18, 2026 · 3:59 PM UTC

Trulieve Cannabis (TRLV) Accumulated Expenses (2020 - 2022)

Trulieve Cannabis (TRLV) posted quarterly Accumulated Expenses of $6.6 million for Q4 2022, down 23.23% year-over-year from $8.6 million in Q4 2021, and down 54.99% quarter-over-quarter from $14.6 million in Q1 2022.

Trulieve Cannabis (TRLV) Accumulated Expenses (2020 - 2022) Analysis & Trends

Trulieve Cannabis' Accumulated Expenses history runs 3 years deep, the most recent figure standing at $6.6 million for Q4 2022.

  • In Q4 2022, Accumulated Expenses fell 23.23% year-over-year to $6.6 million; the TTM figure through Dec 2022 stood at $6.6 million (down 23.23% YoY), while the FY2022 annual figure was $6.6 million, down 23.23% from the prior year.
  • Accumulated Expenses for Q4 2022 stood at $6.6 million, down from $14.6 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $14.6 million in Q1 2022, with the low at $5.6 million in Q4 2020.
  • The 3-year median for Accumulated Expenses is $7.6 million (2021), against an average of $8.9 million.
  • The sharpest annual moves came in 2021 and 2022: Accumulated Expenses soared 53.11% in 2021, then dropped 23.23% in 2022.
  • Trulieve Cannabis' Accumulated Expenses stood at $5.6 million in 2020, then surged by 53.11% to $8.6 million in 2021, then decreased by 23.23% to $6.6 million in 2022.
  • Business Quant data shows TRLV's Accumulated Expenses at $6.6 million in Q4 2022, $14.6 million in Q1 2022, and $8.6 million in Q4 2021.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2022 6.59 Mn
Mar 31, 2022 14.64 Mn
Dec 31, 2021 8.58 Mn
Dec 31, 2020 5.61 Mn